Table 2.
Outcomes at each visit by the treatment group
| Variables | Control group (n = 13) | Treatment group (n = 16) | |||
|---|---|---|---|---|---|
| ADAS-COG | Visit | Mean | Standard deviation | Mean | Standard deviation |
| 0 | 29.23 | 8.90 | 26.44 | 11.93 | |
| 3 | 27.00 | 10.61 | 25.93 | 12.82 | |
| 6 | 27.91 | 10.12 | 26.83 | 15.14 | |
| 12 | 33.17 | 18.62 | 29.92 | 14.13 | |
| ADCS-ADL | |||||
| 0 | 46.62 | 7.57 | 49.06 | 10.26 | |
| 3 | 44.25 | 10.08 | 50.21 | 11.27 | |
| 6 | 45.09 | 12.74 | 48.83 | 10.28 | |
| 12 | 40.50 | 13.27 | 49.33 | 10.51 | |
| MMSE | |||||
| 0 | 19.42 | 3.78 | 18.07 | 4.86 | |
| 3 | 19.58 | 3.90 | 19.21 | 5.65 | |
| 6 | 18.27 | 4.98 | 19.83 | 4.84 | |
| 12 | 15.42 | 6.54 | 16.92 | 7.67 | |
| NPI | |||||
| 0 | 7.92 | 11.78 | 5.44 | 5.90 | |
| 3 | 11.67 | 17.56 | 3.36 | 6.89 | |
| 6 | 8.73 | 9.42 | 5.08 | 8.35 | |
| 12 | 10.17 | 11.03 | 6.25 | 7.51 | |
Abbreviations: ADAS-cog, Alzheimer's Disease Assessment Scale–cognitive subscale; MMSE, Mini–Mental State Examination; ADCS-ADL, Alzheimer's Disease Cooperative Study–Activities of Daily Living Scale; NPI, Neuropsychiatric Inventory.